Xenical Switch Proposal Slated For Advisory Committee Review In January
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees will meet Jan. 23 to review GSK’s application for over-the-counter use of 60 mg orlistat.